Literature DB >> 9008301

Initial characterization of autoprocessing and active-center mutants of CMV proteinase.

S W Snyder1, R P Edalji, F G Lindh, K A Walter, L Solomon, S Pratt, K Steffy, T F Holzman.   

Abstract

Human cytomegalovirus (CMV) encodes a unique serine proteinase that is required in the maturation of the viral capsid. The CMV proteinase can undergo autocatalytic activation and is subject to proteolytic self-inactivation. Mutant enzyme forms were prepared to eliminate the initial autoprocessing site and thus form an active single-chain protein for structure-function studies. Two mutants of CMV proteinase were cloned and expressed in Escherichia coli. The A143V mutant was a conservative substitution at the first internal cleavage site. The S132A mutant modified one of the triad of residues responsible for catalytic activity. Through the use of computer-controlled high-cell-density fermentations the mutant proteins were expressed in E. coli at approximately 170 mg/L as both soluble (approximately 40% of total) and inclusion-body forms (approximately 60% of total). The soluble enzyme was purified by standard methods; inclusion-body protein was isolated by standard methods after refolding and solubilization in guanidine or urea. Sedimentation equilibrium and sedimentation velocity analyses reveal that the enzyme undergoes concentration-dependent aggregation. It exhibits a monomer <==> dimer equilibrium (Kd = 1 microM) at low concentrations and remains dimeric at high concentrations (28 mg/ml). Differential scanning calorimetry data for protein thermal unfolding fit best to a non-two-state model with two components (Tm = 52.3 and 55.3 degrees C) which subsequently aggregate upon unfolding. Analysis of the short-UV circular dichroism spectra of protein forms resulting from expression as soluble molecules (not refolded) reveals that the two mutants have very similar secondary structures which comprise a mixed structural motif of 20% alpha-helix, 26% beta-sheet, and 53% random coil. Though soluble and active (A143V mutant only), CD analysis revealed that protein refolded from inclusion bodies did not exhibit spectra identical to that of protein expressed only in soluble form.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9008301     DOI: 10.1007/bf01887151

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  18 in total

1.  A herpesvirus maturational proteinase, assemblin: identification of its gene, putative active site domain, and cleavage site.

Authors:  A R Welch; A S Woods; L M McNally; R J Cotter; W Gibson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  Cytomegalovirus assemblin: the amino and carboxyl domains of the proteinase form active enzyme when separately cloned and coexpressed in eukaryotic cells.

Authors:  M R Hall; W Gibson
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Expression and analysis of the human cytomegalovirus UL80-encoded protease: identification of autoproteolytic sites.

Authors:  E Z Baum; G A Bebernitz; J D Hulmes; V P Muzithras; T R Jones; Y Gluzman
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

5.  An interactive graphic program for calculating the secondary structure content of proteins from circular dichroism spectrum.

Authors:  G Deléage; C Geourjon
Journal:  Comput Appl Biosci       Date:  1993-04

6.  The effect of internal autocleavage on kinetic properties of the human cytomegalovirus protease catalytic domain.

Authors:  D R O'Boyle; K Wager-Smith; J T Stevens; S P Weinheimer
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

7.  Single-chain recombinant human cytomegalovirus protease. Activity against its natural protein substrate and fluorogenic peptide substrates.

Authors:  C Pinko; S A Margosiak; D Vanderpool; J C Gutowski; B Condon; C C Kan
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

8.  Human cytomegalovirus proteinase: candidate glutamic acid identified as third member of putative active-site triad.

Authors:  G A Cox; M Wakulchik; L M Sassmannshausen; W Gibson; E C Villarreal
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Inhibition of human cytomegalovirus UL80 protease by specific intramolecular disulfide bond formation.

Authors:  E Z Baum; M M Siegel; G A Bebernitz; J D Hulmes; L Sridharan; L Sun; K Tabei; S H Johnston; M J Wildey; J Nygaard; T R Jones; Y Gluzman
Journal:  Biochemistry       Date:  1996-05-07       Impact factor: 3.162

10.  Dimerization of the human cytomegalovirus protease: kinetic and biochemical characterization of the catalytic homodimer.

Authors:  S A Margosiak; D L Vanderpool; W Sisson; C Pinko; C C Kan
Journal:  Biochemistry       Date:  1996-04-23       Impact factor: 3.162

View more
  2 in total

1.  Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.

Authors:  Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

2.  Domain structure analysis of elongation factor-3 from Saccharomyces cerevisiae by limited proteolysis and differential scanning calorimetry.

Authors:  U S Ladror; D A Egan; S W Snyder; J O Capobianco; R C Goldman; S A Dorwin; R W Johnson; R Edalji; A V Sarthy; T McGonigal; K A Walter; T F Holzman
Journal:  Protein Sci       Date:  1998-12       Impact factor: 6.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.